Sponsor Pipeline

Antag Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-24 NCT07724340 A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With… Phase 2 Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07724340 A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With… Adults With Overweight/Obesity and Type 2 Diabetes Recruiting
Disease Areas
Type 2 Diabetes (1) Diabetes (1) Obesity (1)
Get alerts when Antag Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free